Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on May 14, 2024
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
7,133 cr
Turnover Ratio
18.67%
Expense Ratio
0.92%
Exit Load
1.00%
if redeemed within
Returns
- 1M: 0.62%
- 1Y: 52.10%
- 3M: 0.01%
- 3Y: 15.45%
- 6M: 19.38%
- 5Y: 25.52%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
32.590 | 56.31% | 3,835 cr | 1.04% | - | ||
391.033 | 53.16% | 2,667 cr | 0.95% | - |
Other plans of Nippon India Pharma